All articles tagged with #breastcancer
An increasing number of breast cancer survivors are choosing to go flat after mastectomy, reflecting a cultural shift towards body autonomy and redefining recovery and beauty, with many opting out of reconstruction for personal, faster recovery reasons.
Breast cancer rates are rising alarmingly among American women in their 20s and 30s, with metastatic cases increasing by nearly 3% from 2004 to 2021. This trend is partly attributed to current screening guidelines that recommend mammograms starting at age 40, potentially delaying early detection in younger women. The COVID-19 pandemic further exacerbated this issue by limiting access to regular checkups. Experts emphasize the need for earlier screening and awareness to improve survival rates, as younger women often face more aggressive cancer types and lower survival odds.
A new analysis by the Silent Spring Institute suggests that a strong global plastic treaty could significantly reduce breast cancer rates by targeting chemicals in plastics linked to the disease. The study identifies 414 chemicals associated with breast cancer, with 175 posing the greatest risk due to their links to tumors and hormone disruption. Despite the potential health benefits, recent UN negotiations in South Korea failed to reach a consensus on reducing plastic pollution, with disagreements over whether to focus on limiting production or managing waste.
A study by The University of Texas MD Anderson Cancer Center reveals that some normal breast cells in healthy women exhibit chromosome abnormalities typically linked to invasive breast cancer. Published in Nature, the research found that at least 3% of normal breast cells in 49 healthy women showed aneuploidy, challenging traditional views on breast cancer's genetic origins and potentially affecting early detection methods. The study highlights the risk of false positives in cancer diagnostics and suggests that these cellular changes increase with age, raising questions about when cancer actually begins.
Sarrah Strimel Bentley, a breast cancer survivor, underwent IVF before treatment and had only one embryo. The embryo was carried to term by a surrogate, and she and her partner welcomed a baby boy named Chance. The couple's journey highlights the challenges of preserving fertility during cancer treatment and the joy of overcoming those obstacles to become parents.
Actress Shannen Doherty, known for her roles in "90210" and "Charmed," is battling stage 4 breast cancer that has spread to her brain and bones. Despite the severity of her condition, Doherty remains hopeful for a cure within the next 3-5 years, discussing potential future treatments like T-cell therapy on her podcast with oncologist Dr. Lawrence Piro. She continues to work in the entertainment industry and advocates for a more nuanced perception of stage 4 cancer patients, emphasizing vitality and the ability to lead an active life.
Shannen Doherty, known for her roles in "Charmed" and "90210," shared on her podcast how a minor head injury led to the discovery of her stage 4 breast cancer spreading to her brain. Initially concerned about a potential subdural hematoma, her oncologist Dr. Lawrence Piro ordered a CT scan, which revealed brain metastases. Doherty underwent surgery and brain radiation in January 2023 to address the tumor. Despite the challenges, she remains hopeful about new treatments extending her life and candidly discusses living with terminal cancer, aiming to raise awareness and share her journey with others.
Actress Shannen Doherty discussed her past IVF attempts and concerns about its link to her breast cancer diagnosis on her podcast "Let's Be Clear." Despite her initial belief that IVF contributed to her cancer, studies have shown no significant risk increase. Doherty, who is currently dealing with stage 4 breast cancer that spread to her brain, also talked about her desire to have children and the challenges posed by her health condition, including considering adoption and assessing her ability to provide long-term care for a child.
Stanford researchers, led by Dr. Lingyin Li, have published a study revealing the role of the enzyme ENPP1 in breast cancer progression. ENPP1 breaks down cGAMP, a molecule vital for activating the STING pathway in the immune system, which fights cancer. High levels of ENPP1 in tumors correlate with poor prognosis, while lower levels are associated with better responses to immunotherapy. The study suggests that targeting ENPP1 could enhance immunotherapy effectiveness and that ENPP1 levels could serve as a biomarker for treatment response. This breakthrough has significant implications for the development of new cancer treatments and has sparked interest among pharmaceutical companies in finding ENPP1 inhibitors.